Platinum-based chemotherapy, glutathione metabolic pathway genes, and lung cancer survival

被引：0
|
作者：
Yang, P [1 ]
Williams, B [1 ]
Adjei, A [1 ]
Sun, Z [1 ]
Cunningham, J [1 ]
Pankratz, V [1 ]
Weinshilboum, R [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] Glutathione Pathway Genetic Polymorphisms and Lung Cancer Survival After Platinum-Based Chemotherapy
    Moyer, Ann M.
    Sun, Zhifu
    Batzler, Anthony J.
    Li, Liang
    Schaid, Daniel J.
    Yang, Ping
    Weinshilboum, Richard M.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (03) : 811 - 821
  • [2] Glutathione pathway pharmacogenomics and response to platinum-based chemotherapy of lung cancer.
    Moyer, A.
    Sun, Z.
    Jenkins, G.
    Batzler, A.
    Hildebrandt, M.
    Schaid, D.
    Yang, P.
    Weinshilboum, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S7 - S7
  • [3] Markers of response to platinum-based chemotherapy in lung cancer
    Barr, Martin P.
    MacDonagh, Lauren
    O'Byrne, Kenneth J.
    [J]. LUNG CANCER MANAGEMENT, 2013, 2 (03) : 227 - 239
  • [4] Banf1 Predicts Lung Cancer Survival and Sensitivity to Platinum-Based Chemotherapy
    Plowman, J.
    Bolderson, E.
    Burgess, J.
    Richard, D.
    O'Byrne, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S832 - S832
  • [5] Resistance to platinum-based chemotherapy in lung cancer cell lines
    Jianli Chen
    Nashwa Emara
    Charalambos Solomides
    Hemant Parekh
    Henry Simpkins
    [J]. Cancer Chemotherapy and Pharmacology, 2010, 66 : 1103 - 1111
  • [6] Resistance to platinum-based chemotherapy in lung cancer cell lines
    Chen, Jianli
    Emara, Nashwa
    Solomides, Charalambos
    Parekh, Hemant
    Simpkins, Henry
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (06) : 1103 - 1111
  • [7] XPF polymorphism toward lung cancer susceptibility and survival in patients treated with platinum-based chemotherapy
    Lawania, Shweta
    Sharma, Siddharth
    Singh, Navneet
    Behera, Digamber
    [J]. FUTURE ONCOLOGY, 2018, 14 (11) : 1071 - 1089
  • [8] COMPARISON OF GEFITINIB AND PLATINUM-BASED CHEMOTHERAPY AND ONLY PLATINUM-BASED CHEMOTHERAPY TO TREAT LUNG ADENOCARCINOMA
    Yang, L.
    Fan, J. H.
    Liu, L. L.
    Su, Y.
    Lu, D.
    Huang, J. Y.
    Zhang, H.
    Li, Y.
    Huo, H. D.
    Du, Z. H.
    Liu, G. T.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (03): : 613 - 618
  • [9] Changes in Lung Function during Platinum-based Chemotherapy for Patients with Lung Cancer
    Goetschke, J.
    von Wachter, C.
    Sellmer, L.
    Mertsch, P.
    Kauffmann-Guerrero, D.
    Syunyaeva, Z.
    Alpay, N.
    Tufman, A.
    [J]. PNEUMOLOGIE, 2020, 74 : S54 - S54
  • [10] Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer
    Liu, Jun-Yan
    Zou, Ting
    Yin, Ji-Ye
    Wang, Zhan
    Liu, Chong
    Huang, Han-Xue
    Ding, Fei-Xiang
    Lei, Meng-Rong
    Wang, Ying
    Liu, Min
    Liu, Zhao-Qian
    Tan, Li-Ming
    Chen, Juan
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
12345